device; and extension of its cancer detection technology into other cancers, primarily esophageal. The company’s LuViva device would identify cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix. Guided Therapeutics, Inc. has agreements with Konica Minolta, Inc. for the development of non-invasive esophageal cancer detection product based on its biophotonic technology platform.